TargetMol

Ioxitalamic Acid

Product Code:
 
TAR-T19799
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T19799-1mg1mg£164.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T19799-5mg5mg£261.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T19799-1mL1 mL * 10 mM (in DMSO)£334.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T19799-10mg10mg£342.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T19799-25mg25mg£550.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T19799-50mg50mg£755.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T19799-100mg100mg£1,010.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Ioxitalamic Acid is a medical contrast medium and enhances the contrast of structures or fluids in the body in medical imaging.
CAS:
28179-44-4
Formula:
C12H11I3N2O5
Molecular Weight:
643.942
Purity:
0.986
SMILES:
CC(=O)Nc1c(I)c(C(O)=O)c(I)c(C(=O)NCCO)c1I

References

1. Roux FA, Deschamps JY. Inadvertent intrathecal administration of ionic contrast medium to a dog. Vet Radiol Ultrasound. 2007 Sep-Oct;48(5):414-7. Review. 2. van der Leede H, Jorens PG, Parizel P, Cras P. Inadvertent intrathecal use of ionic contrast agent. Eur Radiol. 2002 Dec;12 Suppl 3:S86-93. Epub 2002 Jun 4. Review. 3. Sergeev PV, Sviridov NK, Poliaev IuA, Shimanovski? NL. [Diagnostic effectiveness and safety of currently available X-ray contrast media]. Vestn Rentgenol Radiol. 1999 Nov-Dec;(6):45-9. Review. Russian.